Clinical Trial Update: HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis [NA]

View source ↗

Summary

Open-label clinical trial evaluating the HairMax LaserComb device for treating seborrheic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seborrheic Dermatitis

Drugs mentioned

• HairMax LaserComb

Snippet

Sponsor: Lexington International, LLC | Conditions: Seborrheic Dermatitis | NA | Status: COMPLETED